Vinee Purohit, D.V.M., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biochemical Phenomena | 1 | 2022 | 59 | 0.770 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 379 | 0.590 |
Why?
|
| Pancreatic Neoplasms | 10 | 2021 | 5443 | 0.550 |
Why?
|
| Mucin-1 | 4 | 2017 | 539 | 0.380 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2021 | 5342 | 0.350 |
Why?
|
| Transcription Factors | 3 | 2021 | 12174 | 0.260 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 9618 | 0.230 |
Why?
|
| Deoxycytidine | 2 | 2018 | 888 | 0.220 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2017 | 627 | 0.180 |
Why?
|
| Metabolome | 2 | 2018 | 1009 | 0.180 |
Why?
|
| Glutamine | 3 | 2017 | 578 | 0.160 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2020 | 1756 | 0.150 |
Why?
|
| Glucose | 4 | 2017 | 4352 | 0.150 |
Why?
|
| Molecular Chaperones | 1 | 2022 | 763 | 0.140 |
Why?
|
| Membrane Potentials | 1 | 2020 | 1090 | 0.140 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 822 | 0.130 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2015 | 78 | 0.130 |
Why?
|
| Cysteine | 1 | 2020 | 897 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2018 | 647 | 0.120 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 5804 | 0.120 |
Why?
|
| Annona | 1 | 2012 | 2 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2018 | 965 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2149 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1769 | 0.090 |
Why?
|
| Phytotherapy | 1 | 2012 | 298 | 0.080 |
Why?
|
| Pentose Phosphate Pathway | 3 | 2017 | 126 | 0.080 |
Why?
|
| Protein Binding | 1 | 2021 | 9344 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2012 | 499 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 8664 | 0.080 |
Why?
|
| Mitochondria | 1 | 2020 | 3682 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2022 | 4756 | 0.060 |
Why?
|
| Glycolysis | 3 | 2017 | 838 | 0.060 |
Why?
|
| Citric Acid Cycle | 2 | 2017 | 234 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1608 | 0.050 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 17173 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2015 | 3631 | 0.050 |
Why?
|
| Signal Transduction | 5 | 2019 | 23653 | 0.050 |
Why?
|
| Cationic Amino Acid Transporter 1 | 1 | 2020 | 5 | 0.040 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2020 | 38 | 0.040 |
Why?
|
| Cystine | 1 | 2020 | 96 | 0.040 |
Why?
|
| SOX9 Transcription Factor | 1 | 2019 | 146 | 0.040 |
Why?
|
| Metaplasia | 1 | 2019 | 326 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2019 | 187 | 0.040 |
Why?
|
| Pancreatic Ducts | 1 | 2019 | 330 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 1755 | 0.030 |
Why?
|
| Digoxin | 1 | 2017 | 246 | 0.030 |
Why?
|
| Mice | 6 | 2022 | 82072 | 0.030 |
Why?
|
| Nitrogen | 1 | 2017 | 345 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2017 | 577 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6401 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2022 | 1360 | 0.030 |
Why?
|
| beta Catenin | 1 | 2019 | 1047 | 0.030 |
Why?
|
| Carbon | 1 | 2017 | 672 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2019 | 788 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 997 | 0.030 |
Why?
|
| Pancreas | 1 | 2020 | 1700 | 0.030 |
Why?
|
| Humans | 12 | 2021 | 768970 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 2674 | 0.030 |
Why?
|
| Ketoglutaric Acids | 1 | 2012 | 76 | 0.020 |
Why?
|
| Cell Movement | 2 | 2015 | 5216 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2019 | 2942 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2012 | 148 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2017 | 10486 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2911 | 0.020 |
Why?
|
| Animals | 6 | 2022 | 169335 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 6131 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 1197 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2022 | 2748 | 0.020 |
Why?
|
| DNA Replication | 1 | 2017 | 1428 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2015 | 3076 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13698 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 3116 | 0.020 |
Why?
|
| Metabolomics | 1 | 2017 | 1675 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 5763 | 0.020 |
Why?
|
| Necrosis | 1 | 2012 | 1620 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 800 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3629 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3782 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5793 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2012 | 1231 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9565 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2012 | 1337 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4290 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15604 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1973 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 3048 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2732 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2015 | 8317 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2012 | 5033 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 3450 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 3621 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2019 | 19023 | 0.010 |
Why?
|
| Proteome | 1 | 2012 | 1891 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 5801 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12806 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 30046 | 0.010 |
Why?
|
| Models, Biological | 1 | 2012 | 9499 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9549 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 21188 | 0.010 |
Why?
|
| Female | 3 | 2015 | 397515 | 0.010 |
Why?
|